Chinese General Practice ›› 2023, Vol. 26 ›› Issue (25): 3096-3103.DOI: 10.12114/j.issn.1007-9572.2022.0806
• Original Research·Population Health • Previous Articles Next Articles
Received:
2022-12-22
Revised:
2023-04-11
Published:
2023-09-05
Online:
2023-04-27
Contact:
ZHU Wentao
通讯作者:
朱文涛
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0806
基本信息 | 例数 | 百分比(%) | 基本信息 | 例数 | 百分比(%) |
---|---|---|---|---|---|
性别 | 从业状况 | ||||
男 | 365 | 52.75 | 正式员工 | 199 | 28.76 |
女 | 327 | 47.25 | 临时工 | 42 | 6.07 |
年龄(岁) | 钟点工 | 1 | 0.14 | ||
18~29 | 40 | 5.78 | 个体及自由职业者 | 87 | 12.57 |
30~39 | 63 | 9.10 | 离/退休 | 191 | 27.60 |
40~49 | 162 | 23.41 | 学生 | 26 | 3.76 |
50~59 | 170 | 24.57 | 务农 | 80 | 11.56 |
≥60 | 257 | 37.14 | 无业 | 62 | 8.96 |
民族 | 其他 | 4 | 0.58 | ||
汉族 | 645 | 93.21 | 慢性病种类a | ||
少数民族 | 47 | 6.79 | 高血压 | 275 | 39.74 |
文化程度 | 高脂血症 | 124 | 17.92 | ||
小学以下 | 48 | 6.94 | 关节炎 | 128 | 18.50 |
小学 | 99 | 14.31 | 糖尿病 | 89 | 12.86 |
初中 | 163 | 23.55 | 心脏病b | 84 | 12.14 |
高中或中专 | 144 | 20.81 | 胃溃疡或十二指肠溃疡 | 52 | 7.51 |
大学专科 | 82 | 11.85 | 慢性肺部疾病c | 35 | 5.06 |
大学本科 | 141 | 20.37 | 骨质疏松症 | 62 | 8.96 |
硕士研究生及以上 | 15 | 2.17 | 哮喘 | 15 | 2.17 |
户口类型 | 卒中或其他脑血管疾病 | 23 | 3.32 | ||
非农业户口 | 424 | 61.27 | 癌症或恶性肿瘤 | 6 | 0.87 |
农业户口 | 268 | 38.73 | 髋骨或股骨骨折 | 9 | 1.30 |
白内障 | 19 | 2.75 | |||
帕金森病 | 1 | 0.14 |
Table 1 Basic information of sampled patients with chronic diseases
基本信息 | 例数 | 百分比(%) | 基本信息 | 例数 | 百分比(%) |
---|---|---|---|---|---|
性别 | 从业状况 | ||||
男 | 365 | 52.75 | 正式员工 | 199 | 28.76 |
女 | 327 | 47.25 | 临时工 | 42 | 6.07 |
年龄(岁) | 钟点工 | 1 | 0.14 | ||
18~29 | 40 | 5.78 | 个体及自由职业者 | 87 | 12.57 |
30~39 | 63 | 9.10 | 离/退休 | 191 | 27.60 |
40~49 | 162 | 23.41 | 学生 | 26 | 3.76 |
50~59 | 170 | 24.57 | 务农 | 80 | 11.56 |
≥60 | 257 | 37.14 | 无业 | 62 | 8.96 |
民族 | 其他 | 4 | 0.58 | ||
汉族 | 645 | 93.21 | 慢性病种类a | ||
少数民族 | 47 | 6.79 | 高血压 | 275 | 39.74 |
文化程度 | 高脂血症 | 124 | 17.92 | ||
小学以下 | 48 | 6.94 | 关节炎 | 128 | 18.50 |
小学 | 99 | 14.31 | 糖尿病 | 89 | 12.86 |
初中 | 163 | 23.55 | 心脏病b | 84 | 12.14 |
高中或中专 | 144 | 20.81 | 胃溃疡或十二指肠溃疡 | 52 | 7.51 |
大学专科 | 82 | 11.85 | 慢性肺部疾病c | 35 | 5.06 |
大学本科 | 141 | 20.37 | 骨质疏松症 | 62 | 8.96 |
硕士研究生及以上 | 15 | 2.17 | 哮喘 | 15 | 2.17 |
户口类型 | 卒中或其他脑血管疾病 | 23 | 3.32 | ||
非农业户口 | 424 | 61.27 | 癌症或恶性肿瘤 | 6 | 0.87 |
农业户口 | 268 | 38.73 | 髋骨或股骨骨折 | 9 | 1.30 |
白内障 | 19 | 2.75 | |||
帕金森病 | 1 | 0.14 |
Figure 1 Histogram of utility value distribution of CQ-11D in measuring health-related quality of life in the total sample of chronic disease patients
Figure 2 Histogram of utility value distribution of SF-6Dv1 in measuring health-related quality of life in the total sample of chronic disease patients
Figure 3 Histogram of utility value distribution of EQ-5D-3L in measuring health-related quality of life in the total sample of chronic disease patients
量表 | CQ-11D | SF-6Dv1 | EQ-5D-3L | VAS |
---|---|---|---|---|
CQ-11D | 1.000 | — | — | 0.427a |
SF-6Dv1 | 0.528a | 1.000 | — | 0.363a |
EQ-5D-3L | 0.538a | 0.625a | 1.000 | 0.345a |
Table 2 Intragroup correlation coefficients of utility value measurement results of CQ-11D,SF-6Dv1 and EQ-5D-3L
量表 | CQ-11D | SF-6Dv1 | EQ-5D-3L | VAS |
---|---|---|---|---|
CQ-11D | 1.000 | — | — | 0.427a |
SF-6Dv1 | 0.528a | 1.000 | — | 0.363a |
EQ-5D-3L | 0.538a | 0.625a | 1.000 | 0.345a |
慢性病 | 例数 | CQ-11D | SF-6Dv1 | EQ-5D-3L |
---|---|---|---|---|
高血压 | 275 | 0.846±0.182 | 0.796±0.137 | 0.875±0.143 |
高脂血症 | 124 | 0.852±0.179 | 0.781±0.135 | 0.870±0.139 |
关节炎 | 128 | 0.832±0.173 | 0.747±0.127 | 0.844±0.137 |
H值 | 5.306 | 13.928 | 7.112 | |
P值 | 0.070 | 0.001 | 0.029 |
Table 3 Table 3 Comparison of values of utility measuring health-related quality of life by CQ-11D,SF-6Dv1,and EQ-5D-3L in patients with hypertension,hyperlipidemia or arthritis
慢性病 | 例数 | CQ-11D | SF-6Dv1 | EQ-5D-3L |
---|---|---|---|---|
高血压 | 275 | 0.846±0.182 | 0.796±0.137 | 0.875±0.143 |
高脂血症 | 124 | 0.852±0.179 | 0.781±0.135 | 0.870±0.139 |
关节炎 | 128 | 0.832±0.173 | 0.747±0.127 | 0.844±0.137 |
H值 | 5.306 | 13.928 | 7.112 | |
P值 | 0.070 | 0.001 | 0.029 |
基本信息 | 例数 | CQ-11D | SF-6Dv1 | EQ-5D-3L |
---|---|---|---|---|
性别 | ||||
男 | 151 | 0.885±0.144 | 0.822±0.123 | 0.907±0.124 |
女 | 124 | 0.799±0.211 | 0.764±0.148 | 0.836±0.156 |
H值 | 21.087 | 9.322 | 18.292 | |
P值 | <0.001 | 0.002 | <0.001 | |
年龄(岁) | ||||
18~29 | 2 | 0.903±0.088 | 0.790±0.065 | 0.829±0.065 |
30~39 | 19 | 0.905±0.084 | 0.847±0.091 | 0.944±0.080 |
40~49 | 48 | 0.888±0.146 | 0.819±0.127 | 0.935±0.103 |
50~59 | 73 | 0.866±0.158 | 0.820±0.132 | 0.892±0.135 |
≥60 | 133 | 0.810±0.209 | 0.766±0.145 | 0.835±0.155 |
H值 | 12.201 | 11.616 | 27.649 | |
P值 | 0.016 | 0.020 | <0.001 |
Table 4 Utility values of the CQ-11D,SF-6Dv1 and EQ-5D-3L measuring health-related quality of life in patients with hypertension by age and gender
基本信息 | 例数 | CQ-11D | SF-6Dv1 | EQ-5D-3L |
---|---|---|---|---|
性别 | ||||
男 | 151 | 0.885±0.144 | 0.822±0.123 | 0.907±0.124 |
女 | 124 | 0.799±0.211 | 0.764±0.148 | 0.836±0.156 |
H值 | 21.087 | 9.322 | 18.292 | |
P值 | <0.001 | 0.002 | <0.001 | |
年龄(岁) | ||||
18~29 | 2 | 0.903±0.088 | 0.790±0.065 | 0.829±0.065 |
30~39 | 19 | 0.905±0.084 | 0.847±0.091 | 0.944±0.080 |
40~49 | 48 | 0.888±0.146 | 0.819±0.127 | 0.935±0.103 |
50~59 | 73 | 0.866±0.158 | 0.820±0.132 | 0.892±0.135 |
≥60 | 133 | 0.810±0.209 | 0.766±0.145 | 0.835±0.155 |
H值 | 12.201 | 11.616 | 27.649 | |
P值 | 0.016 | 0.020 | <0.001 |
基本信息 | 例数 | CQ-11D | SF-6Dv1 | EQ-5D-3L |
---|---|---|---|---|
性别 | ||||
男 | 75 | 0.889±0.137 | 0.812±0.117 | 0.899±0.122 |
女 | 49 | 0.795±0.219 | 0.733±0.147 | 0.824±0.151 |
H值 | 12.887 | 9.519 | 9.000 | |
P值 | <0.001 | 0.002 | 0.003 | |
年龄(岁) | ||||
18~29 | 4 | 0.788±0.340 | 0.847±0.170 | 0.892±0.125 |
30~39 | 11 | 0.947±0.038 | 0.798±0.110 | 0.949±0.090 |
40~49 | 38 | 0.878±0.146 | 0.814±0.128 | 0.931±0.109 |
50~59 | 31 | 0.879±0.133 | 0.782±0.119 | 0.846±0.118 |
≥60 | 40 | 0.787±0.223 | 0.738±0.149 | 0.806±0.160 |
H值 | 16.214 | 7.065 | 23.468 | |
P值 | 0.003 | 0.133 | <0.001 |
Table 5 Utility values of the CQ-11D,SF-6Dv1 and EQ-5D-3L measuring health-related quality of life in patients with hyperlipidemia by age and gender
基本信息 | 例数 | CQ-11D | SF-6Dv1 | EQ-5D-3L |
---|---|---|---|---|
性别 | ||||
男 | 75 | 0.889±0.137 | 0.812±0.117 | 0.899±0.122 |
女 | 49 | 0.795±0.219 | 0.733±0.147 | 0.824±0.151 |
H值 | 12.887 | 9.519 | 9.000 | |
P值 | <0.001 | 0.002 | 0.003 | |
年龄(岁) | ||||
18~29 | 4 | 0.788±0.340 | 0.847±0.170 | 0.892±0.125 |
30~39 | 11 | 0.947±0.038 | 0.798±0.110 | 0.949±0.090 |
40~49 | 38 | 0.878±0.146 | 0.814±0.128 | 0.931±0.109 |
50~59 | 31 | 0.879±0.133 | 0.782±0.119 | 0.846±0.118 |
≥60 | 40 | 0.787±0.223 | 0.738±0.149 | 0.806±0.160 |
H值 | 16.214 | 7.065 | 23.468 | |
P值 | 0.003 | 0.133 | <0.001 |
基本信息 | 例数 | CQ-11D | SF-6Dv1 | EQ-5D-3L |
---|---|---|---|---|
性别 | ||||
男 | 44 | 0.854±0.146 | 0.758±0.123 | 0.865±0.111 |
女 | 84 | 0.820±0.186 | 0.741±0.130 | 0.833±0.149 |
H值 | 0.872 | 0.637 | 1.142 | |
P值 | 0.351 | 0.425 | 0.285 | |
年龄(岁) | ||||
18~29 | 6 | 0.881±0.096 | 0.812±0.109 | 0.883±0.116 |
30~39 | 7 | 0.860±0.052 | 0.819±0.086 | 0.946±0.068 |
40~49 | 30 | 0.842±0.167 | 0.760±0.113 | 0.862±0.108 |
50~59 | 30 | 0.853±0.137 | 0.751±0.126 | 0.837±0.134 |
≥60 | 55 | 0.806±0.208 | 0.722±0.138 | 0.821±0.156 |
H值 | 2.061 | 6.014 | 8.403 | |
P值 | 0.351 | 0.198 | 0.078 |
Table 6 Utility values of the CQ-11D,SF-6Dv1 and EQ-5D-3L measuring health-related quality of life in patients with arthritis by age and gender
基本信息 | 例数 | CQ-11D | SF-6Dv1 | EQ-5D-3L |
---|---|---|---|---|
性别 | ||||
男 | 44 | 0.854±0.146 | 0.758±0.123 | 0.865±0.111 |
女 | 84 | 0.820±0.186 | 0.741±0.130 | 0.833±0.149 |
H值 | 0.872 | 0.637 | 1.142 | |
P值 | 0.351 | 0.425 | 0.285 | |
年龄(岁) | ||||
18~29 | 6 | 0.881±0.096 | 0.812±0.109 | 0.883±0.116 |
30~39 | 7 | 0.860±0.052 | 0.819±0.086 | 0.946±0.068 |
40~49 | 30 | 0.842±0.167 | 0.760±0.113 | 0.862±0.108 |
50~59 | 30 | 0.853±0.137 | 0.751±0.126 | 0.837±0.134 |
≥60 | 55 | 0.806±0.208 | 0.722±0.138 | 0.821±0.156 |
H值 | 2.061 | 6.014 | 8.403 | |
P值 | 0.351 | 0.198 | 0.078 |
[1] |
陈亦晨,陈华,周弋,等. 2002—2020年上海市浦东新区居民主要慢性病早死概率研究[J]. 中国全科医学,2022,25(9):1098-1104. DOI:10.12114/j.issn.1007-9572.2021.02.074.
|
[2] |
World Health Organization. Global status report on noncommunicable diseases 2014[R]. Geneva:World Health Organization,2014.
|
[3] |
国家卫生健康委统计信息中心. 2021中国卫生统计年鉴[M].北京:中国协和医科大学出版社,2021.
|
[4] | |
[5] | |
[6] |
孙晓红,刘珂珂,江华,等. 慢性病保健模型在糖尿病长期管理中的应用研究[J]. 中国全科医学,2018,21(31):3878-3881. DOI:10.12114/j.issn.1007-9572.2018.00.043.
|
[7] |
孙利华. 药物经济学[M]. 3版. 北京:中国医药科技出版社,2015.
|
[8] |
刘国恩,胡善联,吴久鸿,等. 中国药物经济学评价指南2020(中英双语版)[M]. 北京:中国市场出版社,2020.
|
[9] |
谢诗桐,陈丕楠,贺小宁,等. 国内外普适性健康效用量表综述研究[J]. 中国卫生政策研究,2020,13(8):58-68. DOI:10.3969/j.issn.1674-2982.2020.08.009.
|
[10] |
北京中医药大学管理学院,北京中医药大学中药药物经济学评价研究所. 中医生命质量评价量表[J]. 中国药物经济学,2022,17(5):5-9. DOI:10.12010/j.issn.1673-5846.2022.05.001.
|
[11] |
|
[12] |
国家统计局. 中国统计年鉴[M]. 北京:中国统计出版社,2019.
|
[13] |
伍红艳. 健康效用值测量研究[D]. 沈阳:沈阳药科大学,2012.
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] | |
[19] | |
[20] |
|
[21] |
|
[22] |
萨建,刘桂芬. 定量测量结果的一致性评价及Bland-Altman法的应用[J]. 中国卫生统计,2011,28(4):409-411,413. DOI:10.3969/j.issn.1002-3674.2011.04.018.
|
[23] |
|
[24] |
|
[25] |
|
[1] | LIN Kai, YAO Mi, CHEN Zhang, JI Xinxin, LIN Runqi, CHEN Yongsong, Sim MOIRA. Conceptual Framework and Responding Approach of Treatment Burden of Type 2 Diabetes: a Video Recording-based Analysis [J]. Chinese General Practice, 2023, 26(34): 4302-4307. |
[2] | YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172. |
[3] | PAN Ye, LIU Zhihui, HU Qianqian, WANG Liuyi. Patterns of Coexistence of Multiple Chronic Conditions among Chinese Elderly [J]. Chinese General Practice, 2023, 26(29): 3608-3615. |
[4] | WANG Xiaoran, ZHANG Dan. Influence of Multimorbidity on Anxiety Symptoms among Chinese Elderly People: a Propensity Score-matched Study [J]. Chinese General Practice, 2023, 26(29): 3622-3627. |
[5] | GUO Jia, SUN Huajun, CHEN Ying, ZHANG Jiawen, ZHANG Yaxin, MA Ying, DU Yue. Construction of On-site Evaluation Index System for Integration of Medical and Preventive Services for Chronic Diseases in Primary Health Care Institutions [J]. Chinese General Practice, 2023, 26(28): 3489-3495. |
[6] | CHENG Xiaoran, ZHANG Xiaotian, LI Mingyue, CHENG Haozhe, TANG Haoqing, ZHENG Huixian, ZHANG Baisong, LIU Xiaoyun. Impact of Chronic Diseases Follow-up on Health Behaviors and Blood Pressure/Glucose Control of Patients with Hypertension and Diabetes in the Context of Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(28): 3482-3488. |
[7] | SUN Mengjie, LIU Lamei, WANG Jia'nan, WANG Peng, ZHANG Zhenxiang. A Meta-synthesis of Qualitative Studies on the Real Experiences and Care Experience during Hospital-to-home Transition for Elderly Patients with Chronic Diseases [J]. Chinese General Practice, 2023, 26(28): 3565-3572. |
[8] | GAO Yanli, WANG Hongjun, SUN Fei, JI Xiangqin, Changizi Roohollah. Exploration of Chronic Disease Management Model in Secondary Private General Hospital [J]. Chinese General Practice, 2023, 26(28): 3585-3590. |
[9] | YANG Hui. Cooperated and Shared Care: Reflections on Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(22): 2711-2714. |
[10] | DENG Hongyu, WU Miaomiao, YANG Zheng, HE Yang, ZHU Linlin, ZHAO Qian, DAI Hua, WU Jia, LIAO Xiaoyang, ZHANG Yonggang. Construction of an Innovative Model of Chronic Disease Management in Compact County Medical Alliance with Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(22): 2720-2725. |
[11] | FENG Jia, WANG Jie, YU Dan, LIU Yongheng, ZHAO Weidong, TIAN Hongyuan. Analysis of Research Hotspots of Multiple Chronic Conditions in the Elderly in 2010-2021 [J]. Chinese General Practice, 2023, 26(21): 2574-2580. |
[12] | ZHANG Xingshan, LIN Yue, WAN Chonghua, SONG Aifeng, PAN Haiyan. A Nephrotic Syndrome-specific Quality of Life Scale: Development Based on the Quality of Life Instruments for Chronic Diseases, and Verification Using the Classical Test Theory [J]. Chinese General Practice, 2023, 26(20): 2488-2495. |
[13] | NI Jianxiao, GAO Guangying, ZHAO Ning, LI Jin, XU Jiajie, WU Nina, YANG Jia. Measurement of the Capitation-based Reimbursement Standard for Chronic Disease Management in Primary Care Clinics [J]. Chinese General Practice, 2023, 26(19): 2355-2360. |
[14] | SONG Hualong, GAO Ying. Association between Serum Uric Acid and the Risk of Type 2 Diabetes Mellitus: a Population-based Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(15): 1831-1839. |
[15] | WANG Feiyue, LU Xiaoqin, JIN Guanghui. Research Progress on Quality Evaluation of Chronic Disease Management in General Practice [J]. Chinese General Practice, 2023, 26(13): 1648-1654. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||